We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

27 hedge funds and large institutions have $6.08M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

38% more capital invested

Capital invested by funds: $4.4M → $6.08M (+$1.68M)

8% more funds holding

Funds holding: 25 → 27 (+2)

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$547K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$407K
3
TI
Telemetry Investments
New York
+$387K
4
Renaissance Technologies
Renaissance Technologies
New York
+$242K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$121K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$1.04M
2
Millennium Management
Millennium Management
New York
-$255K
3
MFG
Magnus Financial Group
New York
-$82K
4
Squarepoint
Squarepoint
New York
-$65K
5
TRCT
Tower Research Capital (TRC)
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.9M +$547K +9,969 +35%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.17M +$242K +4,412 +23%
PCM
3
Palisade Capital Management
New Jersey
$1.04M – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$581K +$407K +7,403 +167%
TI
5
Telemetry Investments
New York
$559K +$387K +7,043 +162%
Northern Trust
6
Northern Trust
Illinois
$111K +$8.51K +155 +7%
Two Sigma Advisers
7
Two Sigma Advisers
New York
$108K +$121K +2,196 New
Morgan Stanley
8
Morgan Stanley
New York
$82K +$54K +984 +142%
Two Sigma Investments
9
Two Sigma Investments
New York
$80K +$89.5K +1,629 New
VF
10
Virtu Financial
New York
$72K +$56.7K +1,032 +242%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$66K +$73.6K +1,341 New
Thrivent Financial for Lutherans
12
Thrivent Financial for Lutherans
Minnesota
$57K +$37.1K +675 +139%
BlackRock
13
BlackRock
New York
$48K – – –
SSWM
14
Smith Salley Wealth Management
North Carolina
$48K +$39.6K +721 +272%
HF
15
HRT Financial
New York
$29K +$33.4K +609 New
SPIA
16
Steward Partners Investment Advisory
New York
$28.8K +$7.58K +138 +31%
Fifth Third Bancorp
17
Fifth Third Bancorp
Ohio
$27K +$30.5K +556 New
QCG
18
Quadrant Capital Group
Ohio
$20K +$22K +400 New
Victory Capital Management
19
Victory Capital Management
Texas
$12K +$13K +236 New
SFA
20
Sequoia Financial Advisors
Ohio
$11K – – –
CA
21
Cetera Advisors
Colorado
$11K +$12.2K +222 New
NFG
22
Next Financial Group
Texas
$9K – – –
VFA
23
Valeo Financial Advisors
Indiana
$7K +$7.3K +133 +2,660%
EWM
24
Elmwood Wealth Management
California
$4K +$4.01K +73 New
Wells Fargo
25
Wells Fargo
California
$3K +$3.02K +55 +688%
1
2

FRTX Hedge Fund Activity: Q1 2021 in Review

27 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2021, worth a combined $6.08M — up 38% from $4.4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new FRTX positions and 6 closed out — a net gain of 3 holders — while 13 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $547K. The largest seller was Anson Funds Management, exiting entirely with an estimated $1.04M sold.

  • 27 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2021, up from 25 in Q4 2020.
  • Funds reported $6.08M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2021, up 38% quarter-over-quarter.
  • 9 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2021 and 6 closed out, a net change of +3 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2021 was Vanguard Group, an estimated $547K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2021 was Anson Funds Management, an estimated $1.04M sold.

Based on aggregated 13F filings for Q1 2021.